Rusfertide rapidly decreases hematocrit in patients with suboptimally controlled polycythemia vera.
Saved in:
| Title: | Rusfertide rapidly decreases hematocrit in patients with suboptimally controlled polycythemia vera. |
|---|---|
| Authors: | Chew LP; Hospital Umum Sarawak, Malaysia. Electronic address: leepingc@moh.gov.my., Ginzburg YZ; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Kirubamoorthy K; Hospital Raja Permaisuri Bainun, Malaysia., Lee SE; Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Republic of Korea., Lee JH; Gachon University Gil Medical Center, Republic of Korea., Modi NB; Protagonist Therapeutics, Inc., Newark, CA, USA., Khanna S; Protagonist Therapeutics, Inc., Newark, CA, USA., Dinh P; Protagonist Therapeutics, Inc., Newark, CA, USA., Valone F; Protagonist Therapeutics, Inc., Newark, CA, USA., Molina A; Protagonist Therapeutics, Inc., Newark, CA, USA., Gupta S; Protagonist Therapeutics, Inc., Newark, CA, USA. |
| Source: | Leukemia research [Leuk Res] 2025 Dec; Vol. 159, pp. 108132. Date of Electronic Publication: 2025 Oct 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5835 (Electronic) Linking ISSN: 01452126 NLM ISO Abbreviation: Leuk Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
